EVALUATION, ASSAYS AND TREATMENT OF PKALMEDIATED DISORDERS

HYPOXIA BIOMARKER AND USE THEREOF

EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS

Evaluation, assays and treatment of pKal-mediated disorders

Kits for labeling of biomarkers and methods of using the same

Biomarkers of latent tuberculosis infection

Screening method for candidate substances for active component to prevent or treat at least one disease selected from the group consisting of renal hypofunction, chronic kidney disease and kidney failure

Method and systems for creating and screening patient metabolite profile to diagnose current medical condition, diagnose current treatment state and recommend new treatment regimen

Physiologic insulin-sensitivity improvement

Biomarkers for the early detection of Parkinson's disease

METHOD FOR DIAGNOSING EARLY ONSET OF ALZHEIMER'S DISEASE OR MILD COGNITIVE IMPAIRMENT

VALIDATING BIOMARKER MEASUREMENT

HUMAN BETA-ADRENERGIC RECEPTOR KINASE POLYPEPTIDE AND METHODS

Method for screening for autophagy activator or inhibitor

Fluorescence method for sensing chlorinated disaccharides

Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment

STRESS AND INFLAMMATION BIOMARKER URINE PANEL FOR DAIRY COWS AND BEEF CATTLE

USE OF BUFODIENOLIDES IN DIAGNOSING AND TREATING ESSENTIAL HYPERTENSION

Alpha-keto-isovalerate as a biomarker of prebiotic efficacy for weight gain prevention

Indoxyl sulfate as a biomarker of prebiotic efficacy for weight gain prevention

Angiopoietin-related protein 4 (cAngptl4) as a diagnostic biomarker for acute lung damage

Methods of determining levels of cleaved and/or intact kininogen

Assays for determining levels of plasma protease C1 inhibitor

Isovalerylglycine as biomarker for the predispositon for weight gain and obesity

Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment

Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment

HUMAN BETA-ADRENERGIC RECEPTOR KINASE POLYPEPTIDE AND METHODS

HUMAN ADAPTATION OF H5 INFLUENZA

Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment

OxMIF as a diagnostic marker

Antibodies to human β-adrenergic receptor kinase

Human β-adrenergic receptor kinase polypeptide and methods

Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof